[Bleomycin, an antimitotic antibiotic, in the treatment of ORL and cervico-facial epidermoid epitheliomas].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004428:Ear Neoplasms / Q000188:drug therapy; D005153:Facial Neoplasms / Q000188:drug therapy*; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D009062:Mouth Neoplasms / Q000188:drug therapy*; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy; D009669:Nose Neoplasms / Q000188:drug therapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin
La bléomycine, antibiotique antimitotique, dans le traitement des épithéliomas épidermoïdes du secteur ORL et cervico-facial.